Trial intelligence / Profile preview

Remune + HAART in Antiretroviral-Naive HIV-1 Patients

NCT00005002Phase 3Unknown

Sponsor
Agouron Pharmaceuticals
Modality
Whole Inactivated Vaccines
Countries
1
01

Overview

A Phase 3 trial of Remune in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Agouron Pharmaceuticals. Status: unknown.

02

Drugs

Remune
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT00005002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call